Table 3.
Variable | Study Subjects (n=18) | Control Subjects (n=17) | P-value |
---|---|---|---|
Total Cholesterol (mg·dL−1) | 186±41 | 212±35 | 0.05 |
HDL Cholesterol (mg·dL−1) | 54±11 | 68±23 | 0.03 |
LDL Cholesterol (mg·dL−1) | 108±39 | 129±23 | 0.09 |
VLDL Cholesterol (mg·dL−1) | 24±13 | 15±6 | 0.02 |
Triglycerides (mg·dL−1) | 120±64 | 77±32 | 0.02 |
C-reactive Protein (mg·dL−1) | 0.50±0.20 | 0.10±0.40 | 0.0001 |
Glucose (mg·dL−1) | 86±14 | 89±13 | 0.48 |
Hematocrit (%) | 39±4 | 37±3 | 0.18 |
FSH (mIU·mL−1) | 62±35 | 66±47 | 0.78 |
LH (IU·L−1) | 24±10 | 26±18 | 0.66 |
Estrone (pg·mL−1) | 38±37 | 26±11 | 0.15 |
Progesterone (ng·mL−1) | 0.35±0.40 | 0.60±0.06 | 0.17 |
All EET’s¥ | 551±228 | 508±258 | 0.65 |
All HETE’s§ | 5307±2921 | 4417±3063 | 0.44 |
FSH=follicular stimulation hormone; LH=luteinizing hormone
Includes the sum of 8,9- EET and DHET, 11,12- EET and DHET, and 14,15- EET and DHET
Includes the sum of 5-,11-,12-,15- and 20 HETE. These were measured in all controls and 17 of the 18 study subjects.